Literature DB >> 1301069

Inactivation of new carbapenem antibiotics by dehydropeptidase-I from porcine and human renal cortex.

M Hikida1, K Kawashima, M Yoshida, S Mitsuhashi.   

Abstract

The stability of the new carbapenem antibiotics, panipenem, meropenem and LJC 10,627, against porcine and human renal dehydropeptidase-I (DHP-I) was compared with that of imipenem. The order of stability to hydrolysis by renal DHP-I was: LJC 10,627 greater than meropenem greater than panipenem greater than imipenem. After incubation of the drugs with porcine or human enzyme at 30 degrees C for 4 h, the percentages of residual activity were as follows: LJC 10,627, 73.7% and 95.6%, respectively; meropenem, 0.2% and 28.7%, respectively; panipenem, 0% and 4.3%, respectively; and imipenem, 0% and 0.1%, respectively. These results demonstrate that LJC 10,627 has extremely high stability against renal DHP-I.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1301069     DOI: 10.1093/jac/30.2.129

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  25 in total

1.  Comparison of the pharmacodynamics of biapenem in bronchial epithelial lining fluid in healthy volunteers given half-hour and three-hour intravenous infusions.

Authors:  Eiki Kikuchi; Junko Kikuchi; Yasuyuki Nasuhara; Satoshi Oizumi; Akitoshi Ishizaka; Masaharu Nishimura
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

2.  Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code.

Authors:  Anne Liu; Lillian Tran; Elinne Becket; Kim Lee; Laney Chinn; Eunice Park; Katherine Tran; Jeffrey H Miller
Journal:  Antimicrob Agents Chemother       Date:  2010-01-11       Impact factor: 5.191

3.  A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Biapenem in Healthy Adult Subjects.

Authors:  David C Griffith; Elizabeth E Morgan; Michael N Dudley; Jeffery S Loutit
Journal:  Antimicrob Agents Chemother       Date:  2021-03-08       Impact factor: 5.191

4.  Deoxycytidine deaminase-deficient Escherichia coli strains display acute sensitivity to cytidine, adenosine, and guanosine and increased sensitivity to a range of antibiotics, including vancomycin.

Authors:  Tina Manzhu Kang; Jessica Yuan; Alice Zhou; Casey Beppler; Jeffrey H Miller
Journal:  J Bacteriol       Date:  2014-03-14       Impact factor: 3.490

Review 5.  Meropenem: a review of its use in patients in intensive care.

Authors:  M Hurst; H M Lamb
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

Review 6.  Panipenem/betamipron.

Authors:  Karen L Goa; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Synergistic interactions of vancomycin with different antibiotics against Escherichia coli: trimethoprim and nitrofurantoin display strong synergies with vancomycin against wild-type E. coli.

Authors:  Alice Zhou; Tina Manzhu Kang; Jessica Yuan; Casey Beppler; Caroline Nguyen; Zhiyuan Mao; Minh Quan Nguyen; Pamela Yeh; Jeffrey H Miller
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

8.  In vitro activity of biapenem (L-627), a new carbapenem, against anaerobes.

Authors:  K E Aldridge; N Morice; D D Schiro
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Authors:  I R Friedland; M Paris; S Ehrett; S Hickey; K Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

10.  Comparative in vitro activity of biapenem, a new carbapenem antibiotic.

Authors:  A M Clarke; S J Zemcov
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.